These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17616354)

  • 1. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
    McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
    J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
    Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
    Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
    Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
    Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
    Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
    Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.
    Martin RJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
    Diabet Med; 2007 Mar; 24(3):259-65. PubMed ID: 17263760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy.
    Loughrey BV; Maxwell AP; Fogarty DG; Middleton D; Harron JC; Patterson CC; Darke C; Savage DA
    Cytokine; 1998 Dec; 10(12):984-8. PubMed ID: 10049523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
    Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
    Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
    Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
    Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.
    Xu M; Chen X; Yan L; Cheng H; Chen W
    J Mol Endocrinol; 2008 May; 40(5):243-51. PubMed ID: 18434430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
    Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
    Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
    Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
    J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection.
    Hussein A; Askar E; Elsaeid M; Schaefer F
    Nephrol Dial Transplant; 2010 Mar; 25(3):779-85. PubMed ID: 19861314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.